Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival

ARAZ Ö., YILMAZEL UÇAR E., MERAL M., Yalcin A., Acemoglu H., DOĞAN H., ...More

CLINICAL RESPIRATORY JOURNAL, vol.9, no.3, pp.297-304, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.1111/crj.12143
  • Title of Journal : CLINICAL RESPIRATORY JOURNAL
  • Page Numbers: pp.297-304

Abstract

IntroductionLung cancer is the most common cause of cancer death in the world, and the most common type is non-small-cell lung cancer (NSCLC). At present, surgical resection, chemotherapy, and radiation therapy are the main treatments for patients with NSCLC, but unfortunately outcome remains unsatisfactory.